Cure My Disease

Don't miss your cure!

 Log in / Sign up

New injection tested for stubborn heel pain

NCT ID NCT06169319

Completed Symptom relief Sponsor: Endo Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study tested whether two different doses of an injectable drug (EN3835) could safely reduce pain and improve foot function better than a placebo injection in people with long-term plantar fasciitis. It involved 231 adults whose heel pain had lasted at least 6 months and had not improved with standard treatments like rest, physical therapy, or pain relievers. The main goal was to see if the treatment reduced daily heel pain over 12 weeks.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PLANTAR FASCIITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Endo Clinical Site 1

    Georgetown, Texas, 78628, United States

  • Endo Clinical Site 2

    Pasadena, Maryland, 21122, United States

  • Endo Clinical Site 3

    Pinellas Park, Florida, 33782, United States

  • Endo Clinical Site 4

    Bedford, Texas, 76021, United States

  • Endo Clinical Site 5

    Salt Lake City, Utah, 84107, United States

  • Endo Site 10

    Tarzana, California, 91356, United States

  • Endo Site 11

    Fresno, California, 93710, United States

  • Endo Site 12

    Suffolk, Virginia, 23434, United States

  • Endo Site 13

    Corona, California, 92882, United States

  • Endo Site 14

    Sweetwater, Florida, 33172, United States

  • Endo Site 15

    Houston, Texas, 77027, United States

  • Endo Site 16

    Los Angeles, California, 90010, United States

  • Endo Site 17

    Dallas, Texas, 75208, United States

  • Endo Site 18

    Dallas, Texas, 75251, United States

  • Endo Site 19

    Grand Rapids, Michigan, 49525, United States

  • Endo Site 20

    Castro Valley, California, 94546, United States

  • Endo Site 21

    San Francisco, California, 94115, United States

  • Endo Site 22

    San Antonio, Texas, 78258, United States

  • Endo Site 23

    Stonecrest, Georgia, 30038, United States

  • Endo Site 24

    Burleson, Texas, 76028, United States

  • Endo Site 25

    Moore, Oklahoma, 73160, United States

  • Endo Site 26

    Dallas, Texas, 75235, United States

  • Endo Site 27

    Missoula, Montana, 59804, United States

  • Endo Site 28

    O'Fallon, Illinois, 62269, United States

  • Endo Site 30

    Fort Worth, Texas, 76104, United States

  • Endo Site 31

    North Chicago, Illinois, 60064, United States

  • Endo Site 32

    Newport News, Virginia, 23606, United States

  • Endo Site 33

    Overland Park, Kansas, 66211, United States

  • Endo Site 34

    San Antonio, Texas, 78229, United States

  • Endo Site 35

    Shreveport, Louisiana, 71101, United States

  • Endo Site 36

    Malvern, Pennsylvania, 19355, United States

  • Endo Site 37

    Coconut Creek, Florida, 33073, United States

  • Endo Site 38

    Westwood, New Jersey, 07675, United States

  • Endo Site 39

    Portland, Oregon, 97202, United States

  • Endo Site 40

    Los Angeles, California, 90063, United States

  • Endo Site 6

    Encinitas, California, 92024, United States

  • Endo Site 7

    Lawrenceville, Georgia, 30043, United States

  • Endo Site 8

    Tucson, Arizona, 85712, United States

  • Endo Site 9

    McAllen, Texas, 78501, United States

Conditions

Explore the condition pages connected to this study.

PLANTAR FASCIITIS